RxDoctor Payments Data

Katherine Belden, MD

Infectious Disease · Philadelphia, PANPI 1598786857

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in PA, where the typical reported total is $132.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$824,039in research payments, 2019–2025

Across 33 payments — averaging $24,971 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Hoffmann-la Roche Limited$605K
  • Eli Lilly$219K

How this compares

$0 in reported general payments places this provider in the 20th percentile of 457 infectious disease providers in Pennsylvania.

See all infectious disease providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$68,001
Medicare patients
227
Services billed
620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin15$17,462
Vancomycin Hcl13$3,313
CeftriaxoneCeftriaxone Sodium39$1,182
Doxycycline Hyclate31$852
Cefazolin Sodium23$802
Minocycline Hcl26$711
Methenamine Hippurate12$533
Cefadroxil17$489
CefuroximeCefuroxime Axetil11$474
Amoxicillin26$158
Sodium Chloride0.9 % Sodium Chloride16$76

Paid to pharmacies, not to this prescriber.

Other infectious disease in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →